Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Initial Clinical Symptoms and Characterizing Those Leading to the Discovery of CASPR2

NCT04653571 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04653571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04653571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Initial Clinical Symptoms and Characterizing Those Leading to the Discovery of CASPR2
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
January 11, 2021
Completion date
January 20, 2022
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caspr2-antibody, encephalitis autoimmune, paraneoplastic syndromes